Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for hyponatremia after hypotonic fluid infusion.
Shirai Y, Miura K, Shimizu S, Hattori M, Shimizu N. Shirai Y, et al. Among authors: shimizu s, shimizu n. Pediatr Int. 2019 Dec;61(12):1239-1243. doi: 10.1111/ped.14000. Epub 2019 Dec 13. Pediatr Int. 2019. PMID: 31469462
Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study.
Ban H, Miura K, Kaneko N, Shirai Y, Yabuuchi T, Ishizuka K, Chikamoto H, Akioka Y, Shimizu S, Ishida H, Tanabe K, Hattori M. Ban H, et al. Among authors: shimizu s. Pediatr Nephrol. 2021 Aug;36(8):2433-2442. doi: 10.1007/s00467-021-04951-x. Epub 2021 Feb 4. Pediatr Nephrol. 2021. PMID: 33538912
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Tachiiri T, Minamiguchi K, Taiji R, Sato T, Toyoda S, Matsumoto T, Chanoki Y, Kunichika H, Yamauchi S, Shimizu S, Nishiofuku H, Marugami N, Tsuji Y, Namisaki T, Yoshiji H, Tanaka T. Tachiiri T, et al. Among authors: shimizu s. Cancers (Basel). 2024 Apr 23;16(9):1624. doi: 10.3390/cancers16091624. Cancers (Basel). 2024. PMID: 38730577 Free PMC article.
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.
Querol L, De Sèze J, Dysgaard T, Levine T, Rao TH, Rivner M, Hartung HP, Kiessling P, Shimizu S, Marmol D, Bozorg A, Colson AO, Massow U, Eftimov F; CIDP01 Study Investigators. Querol L, et al. Among authors: shimizu s. J Neurol Neurosurg Psychiatry. 2024 May 10:jnnp-2023-333112. doi: 10.1136/jnnp-2023-333112. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38729747
4,521 results